Retroviral-mediated gene therapy for the treatment of citrullinemia. Transfer and expression of argininosuccinate synthetase in human hematopoietic cells.
Citrullinemia is a recessive genetic disease caused by a deficiency in argininosuccinate synthetase (AS). Retroviruses were used to transduce the human AS gene into cultured human cells. Using amphotropic viruses with high titer (> 10(6) cfu/ml), we were able to correct the defect in cultured fibroblasts from citrullinemic patients. Retroviral transduction of the human AS gene into human bone marrow cells was also studied. Co-cultivation was used to infect the cells and up to 80% of progenitor cells were found to be carrying and expressing the AS retrovirus after infection. When the infected cells were kept in culture, integration and expression of the retrovirus was observed. Retroviral sequences were present and expressed in the cultured bone marrow-derived cells for up to 10 weeks.
Demarquoy
J
J
Institute for Molecular Genetics, Baylor College of Medicine, Houston, Texas 77030.
D000592:Amino Acid Metabolism, Inborn Errors / Q000628:therapy*; D001124:Argininosuccinate Synthase / Q000235:genetics*; D001853:Bone Marrow / Q000201:enzymology*; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D002956:Citrulline / Q000097:blood*; D005347:Fibroblasts; D015316:Genetic Therapy; D006801:Humans; D012190:Retroviridae / Q000235:genetics*; D014162:Transfection
D002956:Citrulline; D001124:Argininosuccinate Synthase